On May 18, the Collaborative for Cannabinoid Science and Safety (CCSS) sent a letter to U.S. Senators Durbin and Braun commending their introduction of the Dietary Supplement Listing Act of 2022 (S.4090). If passed, this bill would require dietary supplement manufacturers to list their products with the Food and Drug Administration (FDA). Read the full letter here.
Last Updated on May 31, 2022 by Aimed Alliance
